Effect of preoperative Olanzapine on the incidence of postoperative nausea and vomiting
Not Applicable
- Conditions
- Health Condition 1: N72- Inflammatory disease of cervix uteriHealth Condition 2: N709- Salpingitis and oophoritis, unspecified
- Registration Number
- CTRI/2024/03/063683
- Lead Sponsor
- Dr Prasanta Kumar Das
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Gynecological patients undergoing laparoscopic surgeries
ASA 1 and 2
Exclusion Criteria
no consent, allergic to study drugs, renal and hepatic failure, on antiemetic and antipsychotic medications, prolonged qt interval, history of obstructive sleep apnea
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the incidence of PONV in first 24 hours after surgery between two groupsTimepoint: To compare the incidence of PONV in first 24 hours after surgery between two groups
- Secondary Outcome Measures
Name Time Method Quality of recovery(QoR - 15)Timepoint: over 24 hours;requirement of rescue antiemetic (inj.Metoclopramide 10mg IV)Timepoint: 12 hours;severity of nausea and vomting by 4- point severity scaleTimepoint: over 24 hours;Side effects of OlanzapineTimepoint: over 24 hours